A detailed history of Zhang Financial LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zhang Financial LLC holds 2,472 shares of GILD stock, worth $228,833. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,472
Previous 11,635 78.75%
Holding current value
$228,833
Previous $798,000 74.06%
% of portfolio
0.01%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$66.59 - $83.99 $610,164 - $769,600
-9,163 Reduced 78.75%
2,472 $207,000
Q2 2024

Jul 19, 2024

SELL
$63.15 - $72.88 $225,824 - $260,618
-3,576 Reduced 23.51%
11,635 $798,000
Q1 2024

Apr 24, 2024

BUY
$71.58 - $87.29 $129,345 - $157,733
1,807 Added 13.48%
15,211 $1.11 Million
Q4 2023

Jan 31, 2024

BUY
$73.27 - $83.09 $286,046 - $324,383
3,904 Added 41.09%
13,404 $1.09 Million
Q3 2023

Oct 11, 2023

SELL
$73.94 - $80.67 $389,515 - $424,969
-5,268 Reduced 35.67%
9,500 $711,000
Q2 2023

Jul 18, 2023

BUY
$76.01 - $86.7 $460,696 - $525,488
6,061 Added 69.61%
14,768 $1.14 Million
Q1 2023

May 10, 2023

BUY
$77.31 - $88.08 $231,543 - $263,799
2,995 Added 52.43%
8,707 $722,000
Q4 2022

May 17, 2023

SELL
$62.32 - $89.47 $186,648 - $267,962
-2,995 Reduced 34.4%
5,712 $490,000
Q4 2022

Jan 17, 2023

BUY
$62.32 - $89.47 $5,234 - $7,515
84 Added 1.49%
5,712 $490,000
Q3 2022

Oct 18, 2022

BUY
$59.54 - $68.01 $8,454 - $9,657
142 Added 2.59%
5,628 $347,000
Q2 2022

Jul 14, 2022

BUY
$57.72 - $65.01 $112,380 - $126,574
1,947 Added 55.02%
5,486 $339,000
Q1 2022

Apr 21, 2022

BUY
$57.92 - $72.58 $204,978 - $256,860
3,539 New
3,539 $210,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Zhang Financial LLC Portfolio

Follow Zhang Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zhang Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zhang Financial LLC with notifications on news.